Eli Lilly and Co (NYSE:LLY)
| 588.75 BATS BZX Real-Time Price As of 3:32pm ET |  -3.11 / -0.53%Today’s Change | 309.20 Today|||52-Week Range 629.97 | +60.93% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 591.86 |
| Today’s open | 591.71 |
| Day’s range | 586.25 - 596.12 |
| Volume | 1,806,128 |
| Average volume (3 months) | 3,128,212 |
| Market cap | $570.6B |
Data as of 3:32pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +12.53% |
| Earnings growth (this year) | +9.51% |
| Earnings growth (next 5 years) | +27.44% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 106.8 |
| Price/Sales | 11.60 |
| Price/Book | 53.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNJJohnson & Johnson | +2.48 | +1.63% |
| NVONovo Nordisk | -0.48 | -0.47% |
| NONOFNovo Nordisk | +0.95 | +0.94% |
| MRKMerck | +0.70 | +0.69% |
Data as of 3:32pm ET, 11/30/2023
Financials
| Next reporting date | February 6, 2024 |
| EPS forecast (this quarter) | $2.78 |
| Annual revenue (last year) | $28.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 21.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
